SCHEMBL5574574

SCHEMBL5574574

N#Cc1cccc(Oc2cc(C(F)(F)F)ccc2CC(C(=O)[O-])C(=O)O)c1.[Na+]

nearest known ligand 0.45

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 2/20 0.40
PTGDR2 Q9Y5Y4 4/20 0.45
EPAS1 Q99814 5/20 0.41
PPARA Q07869 1/20 0.40
MRGPRX4 Q96LA9 5/20 0.40
FFAR1 O14842 1/20 0.40
LRRK2 Q5S007 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
VEGFA P15692 1/20 0.38
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574572 0.93 PTGDR2 (0.47) PTGDR2EPAS1PPARGPPARAMRGPRX4
SCHEMBL4874724 0.93 PTGDR2 (0.48) PTGDR2EPAS1PPARGPPARAMRGPRX4
SCHEMBL2393357 0.84 PTGDR2 (0.43) PTGDR2EPAS1MRGPRX4LRRK2VEGFA
SCHEMBL2393446 0.81 PPARG (0.47) PTGDR2EPAS1PPARGPPARAMRGPRX4
SCHEMBL2398431 0.80 MRGPRX4 (0.46) PTGDR2EPAS1MRGPRX4LRRK2TRPV1
SCHEMBL2395800 0.73 EPAS1 (0.46) PTGDR2EPAS1MRGPRX4LRRK2VEGFA
SCHEMBL2393359 0.71 PTGDR2 (0.46) PTGDR2EPAS1MRGPRX4FFAR1LRRK2
SCHEMBL2394657 0.71 EPAS1 (0.46) PTGDR2EPAS1MRGPRX4VEGFA
SCHEMBL5570087 0.69 EPAS1 (0.42) PTGDR2EPAS1MRGPRX4VEGFAHTR2A
SCHEMBL891091 0.69 L3MBTL1 (0.65) PTGDR2EPAS1MRGPRX4LRRK2VEGFA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765768-A1 SUBSTITUTED ACIDS FOR THE TREATMENT OF RESPIRATORY DISEASES AstraZeneca AB (SE) 2007-03-28 EP disclosed
WO-2006005909-A1 SUBSTITUTED ACIDS FOR THE TREATMENT OF RESPIRATORY DISEASES ASTRAZENECA AB (SE) 2006-01-19 WO disclosed